AlphaYouTW
Insider selling
Tim Watkins sold $174K of Contineum Therapeutics, Inc. (CTNM) stock
Tim Watkins, CMO & Head of Development of Contineum Therapeutics, Inc. (CTNM), sold 10,833 shares of CTNM stock worth $174K, per an SEC Form 4 filed Jul 1, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 30, 2026, 1 day before it was made public.
CTNM has moved -17.3% since the trade date, from $16.39 to $13.55 (Sep 21, 2026 close).
- Traded
- Jun 30, 2026
- Disclosed
- Jul 1, 2026
- Filing delay
- 1 day
- Price since
- -17.3%
- Role
- CMO & Head of Development
- Source
- SEC Form 4
More CTNM insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.